tiprankstipranks
Abattis Bioceuticals Corp (ATTBF)
OTHER OTC:ATTBF
US Market
ATTBF
Abattis Bioceuticals
RESEARCH TOOLSreports
Want to see ATTBF full AI Analyst Report?

Abattis Bioceuticals (ATTBF) Income Statement

176 Followers

Abattis Bioceuticals Income Statement

Last quarter (Q4 2019), Abattis Bioceuticals's total revenue was C$226.27K, an increase of 9064.32% from the same quarter last year. In Q4, Abattis Bioceuticals's net income was C$-907.06K. See Abattis Bioceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 19Sep 18Sep 17
Total Revenue
C$ 356.88KC$ 8.37KC$ 0.00
Gross Profit
C$ 241.34KC$ 6.48KC$ 0.00
Operating Expenses
C$ 4.26MC$ 15.84MC$ 6.36M
Depreciation and Amortization
C$ 109.01KC$ 37.36KC$ 90.95K
EBITDA
C$ -2.90MC$ -17.34MC$ -5.34M
Operating Income
C$ -3.96MC$ -17.37MC$ -6.36M
Other Income/Expenses
C$ 895.80KC$ -61.82MC$ -688.46K
Pretax Income
C$ -3.06MC$ -77.65MC$ -7.93M
Net Income
C$ -3.04MC$ -78.01MC$ -7.63M
Per Share Metrics
Basic EPS
C$ -0.01C$ -0.24C$ -0.05
Diluted EPS
C$ -0.01C$ -0.24C$ -0.05
Weighted Average Shares Outstanding
 470.49M 322.64M 148.67M
Weighted Average Shares Outstanding (Diluted)
 470.49M 322.64M 148.67M
Currency in CAD

Abattis Bioceuticals Earnings and Revenue History